Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:05 PM
Ignite Modification Date:
2025-12-24 @ 3:05 PM
NCT ID:
NCT00902759
Eligibility Criteria:
Inclusion Criteria:
* Confirmed pathologic diagnosis of adenocarcinoma of pancreas or periampullary cancers, Stage I, II, or III
* Treatment included surgery alone, or adjuvant treatment with CT and/or RT
* Men and women ≥ 18 years of age
* Residents of the USA
* Surgery performed at TJUH, Philadelphia, PA
* CT or RT performed at TJUH, Jefferson system affiliate hospital, or elsewhere
* Patients receiving neoadjuvant therapy with CT or RT, or both, who subsequently are re-staged and eligible for surgery
Exclusion Criteria:
* The presence of co-morbidities that would preclude involvement in a walking program (wheelchair bound, severe arthritis, dizziness)
* Primary residence outside the USA
* Medical management alone for pancreas or periampullary cancer (i.e. not a surgical candidate)
* Stage IV (metastatic) cancer
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00902759
Study Brief:
Protocol Section:
NCT00902759